Cognitive Impairment
📧 Sign up to get email alerts when something new happens for Cognitive Impairment.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Uppsala-Dalarna Dementia and Gait Project
The Uppsala-Dalarna Dementia and Gait Project, sponsored by Dalarna University, is currently recruiting participants. The study involves sev…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders [NA]
An ongoing clinical trial evaluating cognitive remediation to improve social cognition in schizophrenia and related psychotic disorders, cur…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Optimized Rehabilitation of Older Adults With Hip Fracture and Signs of Cognitive Impairment - Feasibility Study [NA]
This clinical trial update describes a feasibility study in Denmark evaluating an optimized rehabilitation approach for older adults with hi…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: The Efficacy of Modified Olfactory Training for MCI High-Risk Individuals [NA]
A clinical trial protocol examines whether modified olfactory training improves cognitive outcomes in individuals at high risk for Mild Cogn…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Computerized Memory Enhancing Treatment in MCI [NA]
A clinical trial evaluating a computerized memory-enhancing treatment in individuals with mild cognitive impairment has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Effect of Consuming a Mixture of Extracts and DHA on the Mild Cognitive Impairment [NA]
An update on a completed clinical trial evaluating whether a mixture of botanical extracts and DHA affects mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)
This completed study describes a method to identify patients who are highly likely to meet eligibility criteria for an Alzheimer's disease c…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD [Phase 2]
Phase 2 study evaluating the safety and immunogenicity of repeated doses of ABvac40 in adults with Mild Cognitive Impairment or Alzheimer Di…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Exploring and Evaluating the Impact of 'Refresh and Reconnect!' [NA]
Clinical trial update for 'Refresh and Reconnect!' exploring its impact on Mild Cognitive Impairment and related aging-related cognitive con…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Effectiveness of Attention/executivefunctions Training on Prospective Memory Abilities of Parkinson's Disease Subjects with Mild Cognitive Impairment and Healthy Aged Individuals: a Placebo-controlled Study with a Combined Immersive Virtual Reality and Telemedicine Approach [NA]
A completed placebo-controlled clinical trial assesses whether immersive virtual reality and telemedicine-based attention and executive func…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment [Phase 2]
A Phase 2 clinical trial evaluating a single-dose ketamine treatment to improve depressive symptoms in individuals with mild cognitive impai…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
This clinical trial update covers the Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium, sponsored by Ma…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: tDCS Intervention in Primary Progressive Aphasia [NA]
Clinical trial update shows completion of a study investigating transcranial direct current stimulation for Primary Progressive Aphasia, wit…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Mindfulness for Cognition in Early-stage Alzheimer's Disease [NA]
The VA Boston Healthcare System is recruiting for a study to assess mindfulness-based approaches to support cognition in individuals with mi…
-
CLINICAL_TRIALS withdrawal · 2025-01-27Clinical Trial Update: Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study [NA]
A clinical trial investigating brain insulin resistance in Alzheimer’s disease and mild cognitive impairment using intranasal insulin; the s…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update reporting results for CST-2032 and CST-107 in individuals with mild cognitive impairment or mild dementia due …
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) [Phase 3]
An ongoing Phase 3 trial called PROMOTE is evaluating a polypill and RiscOMeter to prevent stroke and cognitive impairment; recruitment is i…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers [Phase 1, Phase 2]
Actinogen Medical completed a Phase 1/2 double-blind, placebo-controlled, dose-ranging trial of Xanamem in healthy elderly volunteers, with …
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Validating the Ain Shams Cognitive Assessment Tool
A clinical trial at Ain Shams University aims to validate a cognitive assessment tool for mild cognitive impairment and dementia. The study …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD) [Phase 2]
Phase 2 XanaCIDD trial evaluating Xanamem in adults with major depressive disorder and cognitive impairment has completed.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Development of an Ensemble Learning-based, Multi-dimensional Sensory Impairment Score to Predict Cognitive Impairment in an Elderly Cohort of Southern Italy
A clinical trial update describes developing an ensemble learning-based multi-dimensional sensory impairment score to predict cognitive impa…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Vortioxetine for Post-COVID-19 Condition [Phase 2]
Phase 2 clinical trial evaluating vortioxetine for Post-COVID-19 condition has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Online Meditation for Mild Cognitive Impairment and Mild Dementia [NA]
Clinical trial update for an online meditation intervention targeting individuals with mild cognitive impairment or dementia, sponsored by K…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: High-frequency tRNS for Sleep Disturbances in Neurocognitive Disorders Due to Vascular Disease [NA]
A completed clinical trial from the Chinese University of Hong Kong evaluating high-frequency transcranial random noise stimulation (tRNS) f…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: CPAP Randomized Controlled Trial [NA]
Sunnybrook Health Sciences Centre is conducting a CPAP-based randomized controlled trial evaluating Obstructive Sleep Apnea and Mild Cogniti…